PT Ekadharma International Tbk (IDX:EKAD)
Indonesia · Delayed Price · Currency is IDR 186.00
0.00 (0.00%)
At close: Feb 19, 2026
IDX:EKAD Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 527,477 | 530,432 | 518,359 | 614,477 | 629,879 | 671,541 | |
Revenue Growth (YoY) | 0.63% | 2.33% | -15.64% | -2.44% | -6.20% | -11.44% |
Cost of Revenue | 372,760 | 366,677 | 346,093 | 424,915 | 406,365 | 447,530 |
Gross Profit | 154,717 | 163,755 | 172,266 | 189,562 | 223,514 | 224,011 |
Selling, General & Admin | 101,894 | 100,212 | 97,439 | 100,475 | 99,953 | 101,853 |
Other Operating Expenses | -638.34 | -602.63 | -346.96 | -2,102 | -6,561 | 5,900 |
Operating Expenses | 101,255 | 99,610 | 97,092 | 98,374 | 93,391 | 107,753 |
Operating Income | 53,461 | 64,145 | 75,174 | 91,188 | 130,123 | 116,258 |
Interest Expense | -1,781 | -1,789 | -1,961 | -1,908 | -2,410 | -3,082 |
Interest & Investment Income | 25,312 | 18,801 | 12,087 | 7,269 | 8,282 | 8,943 |
Earnings From Equity Investments | -65.87 | -47.19 | 94.29 | 113.67 | 22.87 | 135.35 |
Currency Exchange Gain (Loss) | -4,038 | -2,974 | 1,895 | - | 1,807 | 1,400 |
Other Non Operating Income (Expenses) | -39.92 | -39.92 | -35.86 | -72.39 | -207.3 | -133.56 |
EBT Excluding Unusual Items | 72,849 | 78,096 | 87,254 | 96,591 | 137,617 | 123,520 |
Gain (Loss) on Sale of Investments | -30,472 | 3,064 | - | 420.32 | - | - |
Gain (Loss) on Sale of Assets | 233.49 | 458.56 | 118.35 | 900.08 | 103.43 | 2.6 |
Pretax Income | 42,611 | 81,619 | 87,372 | 97,911 | 137,720 | 123,523 |
Income Tax Expense | 12,015 | 17,063 | 13,305 | 19,832 | 29,230 | 27,594 |
Earnings From Continuing Operations | 30,595 | 64,556 | 74,067 | 78,080 | 108,490 | 95,929 |
Minority Interest in Earnings | 918.39 | -120.89 | -2,122 | -1,359 | -4,081 | -2,427 |
Net Income | 31,514 | 64,435 | 71,944 | 76,721 | 104,410 | 93,502 |
Net Income to Common | 31,514 | 64,435 | 71,944 | 76,721 | 104,410 | 93,502 |
Net Income Growth | -60.45% | -10.44% | -6.23% | -26.52% | 11.67% | 26.76% |
Shares Outstanding (Basic) | 3,494 | 3,494 | 3,494 | 3,494 | 3,494 | 3,494 |
Shares Outstanding (Diluted) | 3,494 | 3,494 | 3,494 | 3,494 | 3,494 | 3,494 |
EPS (Basic) | 9.02 | 18.44 | 20.59 | 21.96 | 29.88 | 26.76 |
EPS (Diluted) | 9.02 | 18.44 | 20.59 | 21.96 | 29.88 | 26.76 |
EPS Growth | -60.45% | -10.44% | -6.23% | -26.52% | 11.67% | 26.76% |
Free Cash Flow | 75,800 | 37,511 | 75,148 | 87,080 | 33,936 | 220,620 |
Free Cash Flow Per Share | 21.70 | 10.74 | 21.51 | 24.92 | 9.71 | 63.15 |
Dividend Per Share | 9.000 | 9.000 | 9.000 | 9.000 | 10.000 | 9.000 |
Dividend Growth | - | - | - | -10.00% | 11.11% | 28.57% |
Gross Margin | 29.33% | 30.87% | 33.23% | 30.85% | 35.48% | 33.36% |
Operating Margin | 10.13% | 12.09% | 14.50% | 14.84% | 20.66% | 17.31% |
Profit Margin | 5.97% | 12.15% | 13.88% | 12.49% | 16.58% | 13.92% |
Free Cash Flow Margin | 14.37% | 7.07% | 14.50% | 14.17% | 5.39% | 32.85% |
EBITDA | 72,220 | 81,188 | 92,520 | 108,215 | 150,027 | 137,540 |
EBITDA Margin | 13.69% | 15.31% | 17.85% | 17.61% | 23.82% | 20.48% |
D&A For EBITDA | 18,759 | 17,044 | 17,345 | 17,027 | 19,904 | 21,283 |
EBIT | 53,461 | 64,145 | 75,174 | 91,188 | 130,123 | 116,258 |
EBIT Margin | 10.13% | 12.09% | 14.50% | 14.84% | 20.66% | 17.31% |
Effective Tax Rate | 28.20% | 20.91% | 15.23% | 20.26% | 21.22% | 22.34% |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.